An observational study in Heart Failure, sponsored by The Hospital for Sick Children. Recruiting at 1 site in Canada. Open to participants aged 1 Month to 12 Years. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by The Hospital for Sick Children · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 454 studies in Heart Failure with a site in Canada — 77 open to participants now, 99 under way, 21 of them phase 3. Heart Failure · Canada.
Among the 454 studies in Heart Failure with a site in Canada, this one is the 68th largest by planned enrollment of the 91 observational ones that give a count, is one of 27 that started in 2024, is one of 92 observational ones, reaches primary completion later than 63 of the 98 other live ones, and was the 397th registered.
6,340 studies on the registry are indexed under Heart Failure; 1,397 are open to participants now.
Browse Heart Failure studies →77 of the 454 studies in Heart Failure with a site in Canada are open now. Recruiting first, the newest first:
AnaCardio AB · Sites in Canada, United States, Bulgaria and 5 more countries
Ages 18–85
Samantha Anthony · Sites in Canada
Ages 18–35
AstraZeneca · Sites in Canada, United States, Argentina and 29 more countries
Ages 18+
Ottawa Heart Institute Research Corporation · Sites in Canada
Ages 18+
University Health Network, Toronto · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 968 Heart Failure studies recruiting now, 691 (71%) set no upper age limit and 90 (9%) stop at 75 or younger; 64 take children under 18; 97 take healthy volunteers.
This study: 1 Month to 12 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
454 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 14 · Phase 2 72 · Phase 3 106 · Phase 4 24
First in 1983; this study’s year is marked. 27 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is below the median of 200 across 1,987 observational studies indexed under Heart Failure.
Median enrollment 226 across the 362 interventional studies, 360 across the 91 observational. Of the 307 that completed or were terminated, 127 (41%) have results posted.
This tab as a report to print or save as PDF → With an account.
201 of 454 have an industry lead sponsor. The 10 most frequent:
The Hospital for Sick Children is the lead sponsor of 579 studies on the registry; 81 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
The Hospital for Sick Children has 3 studies filed under Heart Failure — fewer than ten, so there is no comparison to draw.
29 of the studies in Heart Failure with a site in Canada that are under way reach primary completion within a year, 5 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06307652Phase 3AstraZenecaStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function | 2027-04-16 |
| NCT05873881Phase 3Hamilton Health Sciences CorporationCOLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease | 2027-06 |
| NCT06736574Phase 3CytokineticsStudy With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction | 2027-09 |
| NCT06024746Phase 3Colorado Prevention CenterA Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF) | 2027-11 |
| NCT06008197Phase 3Colorado Prevention CenterA Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients | 2027-11 |
Add all 29 to your calendar (.ics) → With an account.
Among the 454 studies in Heart Failure with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The primary research objective is to determine the safety, feasibility, usability and validity of textile-enabled monitoring systems designed to capture physiologic variables, or "biological signals," related to cardiopulmonary function in children through comparison to hospital-based, standard-of-care monitoring in the Sickkids Cardiac Critical Care Unit (CCCU).
This single-arm, non-randomized study is a usability, technology feasibility and data correlation study which will employ a convenience sampling method. The study will compare the quality of data obtained by the Myant Inc Skiin Pediatric Band smart textile device to the gold-standard data generated by the clinical devices in the CCCU at SickKids.
The primary research objective is to determine the safety, feasibility, usability and validity of textile-enabled monitoring systems designed to capture physiologic variables, or "biological signals," related to cardiopulmonary function in children through comparison to hospital-based, standard-of-care monitoring in the SickKids CCCU.
The secondary objectives are as follows; (1) To design textiles for infants and children that allow safe, developmentally appropriate care, (2) To investigate the optimum placement of biosensors to measure physiologic parameters such as heart and respiratory rate within the textile-based approach, (3) To validate the textile-based approach, including the integrated sensors, through comparison to physiologic data gathered as part of routine patient care through traditional comparative analysis, (4) To investigate usability of the textiles, including placement, removal, and effects on patient care activities, and (5) To gather clinician feedback on the textile use and design.
Infants and Children Admitted to the Cardiac Critical Care Unit
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
1. Patients from 1 month of age to 12 years of age who are admitted to SickKids CCCU with expected stays in CCCU longer than 12 hours including those for medical management and post-surgical patients.
Exclusion Criteria:
Eligibility may be reassessed once an appropriate body location for the textile placement becomes available.*
Eligibility may be reassessed after the patient returns to the CCCU.**
Eligibility may be reassessed after the temporary pacemaker has been removed.***
Inclusion Criteria: Patients from 1 month of age to 12 years of age who are admitted to SickKids CCCU with expected stays in CCCU longer than 12 hours including those for medical management and post-surgical patients.
Device: Skiin pediatric band and Skiin biometric pod
Infants that meet the inclusion criteria will be equipped with a Skiin pediatric band appropriate for their chest size. Heart rate, respiratory rate, temperature, and electrocardiogram will be monitored from 2 to 12 hours through the Skiin pediatric band and a standard of care device (Phillips Intellivue MX750) commonly used in the CCCU at SickKids.
Heart Rate
The difference between heart rate measured from Skiin data and from standard of care device.
Time frame: collection during the single study session of 2-12 hours.
Respiratory Rate
The difference between respiratory rate measured from Skiin data and from standard of care device.
Time frame: collection during the single study session of 2-12 hours.
Temperature
The difference between temperature measured from Skiin data and from standard of care device.
Time frame: collection during the single study session of 2-12 hours.
Plan to share: No
Started Jan 2024 (actual). Primary completion is estimated for Dec 2027, 47 months after the start.
Of 799 non-industry observational studies under Heart Failure, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 100. This study's planned 47 months is close to that.
Counting every sponsor, half of 982 studies reached it within 41 months; a quarter within 23 and three quarters within 89.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Jan 2025 → Dec 2027 and completion Jan 2026 → Dec 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The Hospital for Sick Children →